Maritop (Topiramate)

Topiramate works by enhancing the inhibitory neurotransmitter GABA, blocking excitatory glutamate receptors (AMPA/kainate), and inhibiting carbonic anhydrase, which together reduce neuronal hyper‑excitability and help prevent seizures and migraine attacks.

The specific dose of Maritop is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and other factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Topiramate is classified as Pregnancy Category D, indicating potential risk to the fetus. It should be used in pregnancy only if the benefit justifies the risk. Limited data are available for breastfeeding; a decision should be made in consultation with a healthcare professional.

To order Maritop, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other migraine preventives such as beta‑blockers or CGRP monoclonal antibodies, topiramate offers an oral, non‑injectable option with a well‑established efficacy profile. Its side‑effect spectrum differs, and individual response varies, so clinicians choose based on patient tolerance, comorbidities and treatment goals.

Maritop should be stored at room temperature, below 25 °C, in its original packaging. Keep it away from moisture, heat and direct sunlight to maintain product stability.

Maritop is taken orally, usually with water. The tablet should be swallowed whole and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious risks include metabolic acidosis, kidney stone formation, acute angle‑closure glaucoma, severe allergic reactions, and emergence of suicidal thoughts or behaviors. Patients should be monitored for these events and seek immediate medical attention if they occur.

Maritop is contraindicated in patients with known hypersensitivity to topiramate or any of its components. Caution is advised for individuals with severe renal impairment, a history of kidney stones, or those who are pregnant unless the therapeutic benefit outweighs the risk.